Member Info for Joshholdforgold

There were several new pieces of information released last night. The key points for me were:

- Theorem RX will be subject to performance clauses within the contract which prevent the deal from being shelved. 201 will be developed.
- Royalties, will be disclosed at a later date but will be between 6-9%.
- The official deal will be signed and the first payment made before the end of the year. This means the exclusivity period is simply 6 weeks. This time period is cemented within the letter of intent.
- VAL intend to further develop 301 to the point of being clinical trial ready before selling.
- confirmation of no placement to cover working capital for at least 2 years.
- Lucrative service agreement for a minimum of 2 years with Theorem RX. The revenue will ‘pay wages’.
- Nick is too shy to sing in front of Suzy.

Completely agree blue

Yes I’ve been waiting on the sidelines to see that break out. I think it’s coming.

https://m.youtube.com/watch?v=uZjAmpG8fNk

Services to TheoremRX

We are being paid to help develop our drug in addition to them buying the licence.

Deal with multiple 100 mil+ potential value. Cash to fund the business as 301, 401 and bc deals still to come!

Expecting the push to 1.45 i the next few days. First day of the rest of ARBs life.

https://twitter.com/joshblakemore8/status/1454897378507505665?s=21

Take a look at my chart.

Bounce off the £1.10 support and bottom of a rising trend channel suggests to me that a quick move up to £1.45 will follow.

A break from there could see £1.85-1.90 at the top of the channel.

ARB has taken beating recently. BTC rally should help to galvanise recovery. IMHO.

Hands up - last week I called the next leg up too early.

I proposed that we had moved into a new steeper channel after the past interview, which proved to be incorrect on Friday.

HOWEVER, we are still holding the original upward trend channel and this should see our next leg up this week.

Top of the channel this week is at 67p with the bottom of the channel rising from 47p.

It’s only going one way this week.

Chart:

https://twitter.com/joshblakemore8/status/1454883298191290373?s=21

The last week has shown a bullish break out from a symmetrical triangle formed over the last year.

Given the size of the triangle, I expect to see £3-3.50 before results in Q1 next year. Of course should the P3 results replicate P2 we will see the share price much higher.

Chart:

https://twitter.com/joshblakemore8/status/1454891400697421826?s=21

Exciting times ahead. It feels like the beginning of the end.

This is the point webbo. More people did not sell than buy.

LSE reporting shows buys at 1.4m and sells at 700k.

Some sells were misreported as buys but not 700k!

Also I’ve done several dummy sells and dummy buys through this afternoon. As have a few others who I know who trade on other platforms. Each time you can sell in large quantities but only buy in small quantities. Very strange for a stock that’s down 5% on the day.

Conclude what you like from those facts, but there is no doubt it’s a bit weird.

Northern hero - Haha

Ells- was there an organised event with AZ? Do you have any more detail?

Take a look at my revised chart hypothesis.

https://twitter.com/Joshblakemore8/status/1453390504436056065?s=20

This gets said a lot but it’s actually really true today.

One decent buys way from 59p

My forecast for today is that we will see 62p.

Such a strong recovery from a bear trap yesterday shows the underlying appetite for the stock.

Chart: https://twitter.com/joshblakemore8/status/1453000668248219651?s=12

This week may be the week we break up out of this rising channel.

Good luck. Strap in!

I re-read above and it’s hardly my clearest post.

Basically I mean that I think the deal will be:
- £3-8m upfront
- £200m stage payments
- 5% royalties on sales.

Which would give us a mcap as above.

I personally think the value of the deal to us will be the upfront cash £3-8 million. If our upfront was £10m or more, I don’t think the emphasis would have been placed on being ‘back end heavy’.

Then plus about 20% of the milestone payments. Hopefully that’s c£200m.
So that gives 201 value to us this year at £43-48m.

We should also gain more hope value for 301 and 401 once the first deal is signed.

So £60m-80 mcap.

£1.00 - £1.20 post first deal.

I really liked the logic of your Merck PYC theory.
Either would be fantastic.